Entity Common Stock, Shares Outstanding of Cartesian Therapeutics, Inc. from 08 Aug 2016 to 28 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cartesian Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 08 Aug 2016 to 28 Feb 2026.
  • Cartesian Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 28 Feb 2026 was 26,509,024, a 2.1% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Cartesian Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 26,509,024 +554,733 +2.1% 28 Feb 2026 10-K 09 Mar 2026 2025 FY
Q3 2025 26,003,606 +588,708 +2.3% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 26,002,042 +4,619,557 +22% 01 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 25,954,291 -135,994,327 -84% 30 Apr 2025 10-Q 08 May 2025 2025 Q1
Q3 2024 25,414,898 -129,789,284 -84% 01 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 21,382,485 -132,045,086 -86% 07 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 161,948,618 +8,521,635 +5.6% 01 Mar 2024 10-K 07 Mar 2024 2023 FY
Q3 2023 155,204,182 +2,173,085 +1.4% 10 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 153,427,571 +714,360 +0.47% 04 Aug 2023 10-Q 17 Aug 2023 2023 Q2
Q1 2023 153,426,983 +1,617,567 +1.1% 28 Apr 2023 10-Q 04 May 2023 2023 Q1
Q3 2022 153,031,097 +36,382,178 +31% 28 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 152,713,211 +37,633,919 +33% 02 Aug 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 151,809,416 +39,436,217 +35% 22 Apr 2022 10-K/A 28 Apr 2022 2021 FY
Q3 2021 116,648,919 +8,618,608 +8% 05 Nov 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 115,079,292 +7,935,882 +7.4% 06 Aug 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 112,373,199 +25,953,004 +30% 05 Mar 2021 10-K 12 Mar 2021 2020 FY
Q3 2020 108,030,311 +59,833,924 +124% 30 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 107,143,410 +62,180,459 +138% 31 Jul 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 86,420,195 +41,686,758 +93% 06 Mar 2020 10-K 12 Mar 2020 2019 FY
Q3 2019 48,196,387 +25,762,175 +115% 04 Nov 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 44,962,951 +22,566,768 +101% 02 Aug 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 44,733,437 +22,383,597 +100% 08 Mar 2019 10-K 15 Mar 2019 2018 Q4
Q3 2018 22,434,212 +97,636 +0.44% 02 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 22,396,183 +321,805 +1.5% 03 Aug 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 22,349,840 +3,869,702 +21% 09 Mar 2018 10-K 15 Mar 2018 2017 Q4
Q3 2017 22,336,576 +4,146,396 +23% 03 Nov 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 22,074,378 +3,884,198 +21% 04 Aug 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 18,480,138 17 Mar 2017 10-K 28 Mar 2017 2016 FY
Q3 2016 18,190,180 10 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 18,190,180 08 Aug 2016 10-Q 09 Aug 2016 2016 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.